VIGL

VIGL

USD

Vigil Neuroscience Inc. Common Stock

$2.750+0.310 (12.705%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$2.440

Haut

$2.800

Bas

$2.402

Volume

0.05M

Fondamentaux de l'Entreprise

Capitalisation Boursière

128.3M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.22M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $1.312Actuel $2.750Haut $6.06

Actualités Connexes

Analyst Upgrades

Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13

Wedbush analyst Laura Chico maintains Vigil Neuroscience with a Outperform and lowers the price target from $24 to $13.

Voir plus
Wedbush Maintains Outperform on Vigil Neuroscience, Lowers Price Target to $13
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14

HC Wainwright & Co. analyst Andrew Fein maintains Vigil Neuroscience with a Buy and lowers the price target from $17 to $14.

Voir plus
HC Wainwright & Co. Maintains Buy on Vigil Neuroscience, Lowers Price Target to $14
GlobeNewswire

Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

– Announced positive data from Phase 1 clinical trial evaluating VG-3927 for potential treatment of Alzheimer's Disease (AD); plans to initiate Phase 2 clinical trial in Q3 2025 – – On track to report final analysis

Voir plus
Vigil Neuroscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Recent Business Updates

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.